MMPs as therapeutic targets--still a viable option?

Area of Science:

• Biochemistry
• Pharmacology
• Enzymology

Background:

• Matrix metalloproteinases (MMPs) are extracellular enzymes crucial in various physiological and pathological processes.
• Their association with diseases makes them attractive drug targets, particularly due to their zinc-dependent catalytic activity.

Purpose of the Study:

• To explore the complexities of targeting matrix metalloproteinases (MMPs) for therapeutic interventions.
• To address the challenges in developing specific MMP inhibitors and inform future drug trial strategies.

Main Methods:

• Review of existing literature on MMP biology and inhibitor development.
• Analysis of the challenges associated with targeting the catalytic zinc of MMPs.
• Examination of the dual roles of MMPs in disease (harmful vs. healing).

Main Results:

• MMPs exhibit complex roles, with some functions being beneficial, complicating broad-spectrum inhibition.
• Achieving specificity in targeting the catalytic zinc is challenging due to potential off-target effects on other proteins.
• Previous MMP inhibitor trials faced setbacks, necessitating a deeper understanding of MMP basic biology.

Conclusions:

• Targeting MMPs requires a nuanced approach that considers their diverse biological functions.
• Overcoming specificity challenges is critical for the successful development of MMP-targeted therapies.
• Continued research into MMP basic biology is essential for advancing new drug development in this field.